ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

In Brief: William McGuire, Breast Cancer Researcher, Dead of Heart Attack; Attracted Large Group To Texas

April 10, 1992

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

In Brief: Leonidas Platanias named director of Lurie Comprehensive Cancer Center

October 3, 2014